TY  - JOUR
AB  - Biotechnology is typically associated with the centres of learning and firms in industrialised countries but usually not with institutions in developing countries. Developing nations are however, becoming active in this field and are increasingly using recombinant methods to produce new and innovative health products for their populations. Here we will examine health biotechnology development in two developing countries, Brazil and Cuba. We will compare the major characteristics of their health biotechnology sectors and highlight factors that have shaped their development in order to understand better what main factors and conditions can promote health biotechnology innovation in developing countries.
AU  - Halla Þorsteinsdóttir
AU  - Thorsteinsdóttir, Halla
AU  - Þorsteinsdóttir, Halla
AU  - Saenz, Tirso W.
AU  - Singer, Peter A.
AU  - Daar, Abdallah S.
DA  - 2005
LA  - eng
IS  - Journal of Business Chemistry
M2  - 99
N1  - Section "Commentary"
PY  - 2005
SP  - 99-106
T2  - Journal of Business Chemistry
TI  - Different rhythms of health biotechnology development in Brazil and Cuba
UR  - https://nbn-resolving.org/urn:nbn:de:hbz:6-34699357258
Y2  - 2024-11-22T05:01:46
ER  -